Retrovir 100 mg capsules, hard Malta - English - Medicines Authority

retrovir 100 mg capsules, hard

viiv healthcare bv huis ter heideweg, 62, 3705 lz zeist, netherlands - zidovudine - hard capsule - zidovudine 100 mg - antivirals for systemic use

Epivir European Union - English - EMA (European Medicines Agency)

epivir

viiv healthcare bv - lamivudine - hiv infections - antivirals for systemic use - epivir is indicated as part of antiretroviral combination therapy for the treatment of human-immunodeficiency-virus (hiv)-infected adults and children.,

Combivir European Union - English - EMA (European Medicines Agency)

combivir

viiv healthcare bv - lamivudine, zidovudine - hiv infections - antivirals for systemic use - combivir is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.,

Tivicay European Union - English - EMA (European Medicines Agency)

tivicay

viiv healthcare bv - dolutegravir - hiv infections - antivirals for systemic use - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg.tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Telzir European Union - English - EMA (European Medicines Agency)

telzir

viiv healthcare bv - fosamprenavir calcium - hiv infections - antivirals for systemic use - telzir in combination with low-dose ritonavir is indicated for the treatment of human-immunodeficiency-virus-type-1-infected adults, adolescents and children of six years and above in combination with other antiretroviral medicinal products. in moderately antiretroviral-experienced adults, telzir in combination with low-dose ritonavir has not been shown to be as effective as lopinavir / ritonavir. no comparative studies have been undertaken in children or adolescents. in heavily pretreated patients, the use of telzir in combination with low-dose ritonavir has not been sufficiently studied. in protease-inhibitor-experienced patients, the choice of telzir should be based on individual viral resistance testing and treatment history.,

Trizivir European Union - English - EMA (European Medicines Agency)

trizivir

viiv healthcare bv - abacavir (as sulfate), lamivudine, zidovudine - hiv infections - antivirals for systemic use - trizivir is indicated for the treatment of human-immunodeficiency-virus (hiv) infection in adults.this fixed combination replaces the three components (abacavir, lamivudine and zidovudine) used separately in similar dosages. it is recommended that treatment is started with abacavir, lamivudine,and zidovudine separately for the first six to eight weeks. the choice of this fixed combination should be based not only on potential adherence criteria, but mainly on expected efficacy and risk related to the three nucleoside analogues.the demonstration of the benefit of trizivir is mainly based on results of studies performed in treatment naive patients or moderately antiretroviral experienced patients with non-advanced disease.in patients with high viral load (>100,000 copies/ml) choice of therapy needs special consideration.overall, the virologic suppression with this triple nucleoside regimen could be inferior to that obtained with other multitherapies notably including boosted protease inhibitors or non-nucleoside reverse-transcriptase inhibitors, therefore the use of trizivir should only be considered under special circumstances (e.g. co-infection with tuberculosis).before initiating treatment with abacavir, screening for carriage of the hla-b*5701 allele should be performed in any hiv-infected patient, irrespective of racial origin. screening is also recommended prior to re-initiation of abacavir in patients of unknown hla-b*5701 status who have previously tolerated abacavir (see 'management after an interruption of trizivir therapy'). abacavir should not be used in patients known to carry the hla-b*5701 allele, unless no other therapeutic option is available in these patients, based on the treatment history and resistance testing.

Retrovir 10 mg/ml IV concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

retrovir 10 mg/ml iv concentrate for solution for infusion

viiv healthcare bv - zidovudine - concentrate for solution for infusion - 10 milligram(s)/millilitre - nucleoside and nucleotide reverse transcriptase inhibitors; zidovudine

Retrovir 100 mg capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

retrovir 100 mg capsules, hard

viiv healthcare bv - zidovudine - capsule, hard - 100 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; zidovudine

Retrovir 100 mg/10 ml oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

retrovir 100 mg/10 ml oral solution

viiv healthcare bv - zidovudine - oral solution - 100 milligram/ 10 millilitre - nucleoside and nucleotide reverse transcriptase inhibitors; zidovudine

Tivicay 50mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

tivicay 50mg tablets

viiv healthcare uk ltd - dolutegravir sodium - tablet - 50mg